← Back to Clinical Trials
Recruiting Phase 4 NCT06695208

NCT06695208 Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06695208
Status Recruiting
Phase Phase 4
Sponsor Cairo University
Condition Socket Perservation
Study Type INTERVENTIONAL
Enrollment 11 participants
Start Date 2024-12-01
Primary Completion 2025-12-01

Trial Parameters

Condition Socket Perservation
Sponsor Cairo University
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 11
Sex ALL
Min Age 25 Years
Max Age 50 Years
Start Date 2024-12-01
Completion 2025-12-01
Interventions
Biodentine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

socket preservation using biodentin versus xeno graft for single rooted mandibular teeth

Eligibility Criteria

Inclusion Criteria: * Patients of both sex with badly decayed tooth indicated for extraction * The ages of the patients ranged from 25 to 50 years. * Patients with healthy systemic condition (Medically free) * Adequate inter-arch space for placement of the implant prosthetic part. * Good oral hygiene * Cooperative patients who are willing to commit for 6 months follow up Exclusion Criteria: * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Poor oral hygiene and motivation. * Smokers * Patient with medical condition that contraindicates surgical procedures * Pregnant or nursing. * Substance abuse. * Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits severe bruxism or clenching. * Active infection or severe inflammation in the area intended for implant placement. * Patients on medication that may interfere with healing (corticosteroids, bisphosphonate, Ch

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology